1. Patient Selection for Modern T2D Agents

3. Program Goals

4. Patient-Centered Care

5. Modern Antihyperglycemic Agents

6. Case Study Role of DPP-4 Inhibitors

7. Case Discussion

8. Case Study Role of Fixed-dose Combination SGLT2/DPP-4 Inhibitor

9. Case Discussion

10. HbA1c Efficacy of Combination Empagliflozin and Linagliptin and Metformin

11. HbA1c Efficacy of Combination Dapagliflozin and Saxagliptin and Metformin

13. Combination SGLT2/DPP-4 Inhibitor in Treatment-Naïve Patients

14. CV Outcome Trials DPP-4 Inhibitors

15. CV Outcome Trials SGLT2 Inhibitors

16. Safety SGLT2 Inhibitors

17. Case Study Role of GLP-1 Agonists

18. Case Discussion

19. GLP-1 Receptor Agonists

20. Closing Comments

21. Abbreviations